Sharma, Sandhya
Leung, Wingchi K
Heslop, Helen E
Article History
First Online: 7 May 2020
Compliance with Ethical Standards
:
: HEH has ownership interest (including stock, patents, etc.) in Allovir and Marker Therapeutics, and is a consultant/advisory board member for Novartis, Gilead Biosciences, Kiadis, and PACT Pharma and has received commercial research grants from Cell Medica and Tessa Therapeutics. SS and WL have no potential conflicts of interest.